Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or treatment with a real dr.. We aren't doctors. Always consult your mD on Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis Clinical research trials and Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis medical trials occur in many of places across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectiveness of new does drugs. The role of the studies / undertakings is to figure out certain human healthcare questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to locate treatments for all forms of circumstances, including Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis. Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis Clinical Trials and other clinical trials permit volunteers to get medical treatment options before they are available to the masses. Most times the human subjects acquire treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis clinical trial. Participants oftentimes recieve the finest healthcare available for their Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis condition. Dangers are a reality, nonetheless, and might include extra or frequent physician calls, health hazards (potentially life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.

Home > "S" Clinical Trials Conditions > Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis

Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis



Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis

For Condition: Tuberculosis
Status: No longer recruiting
Sponsor(s): Centers for Disease Control and Prevention , Department of Veterans Affairs
Synopsis: This is a randomized, double-blind study of the tolerability of three different doses of rifapentine
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Placebo Control
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: - Patients with tuberculosis
Total Enrollment: 

Location and Contact Information:

Hines VA Medical Center
Hines,  Illinois,  60141
United States
 

Duke University Medical Center
Durham,  North Carolina,  34222
United States
 

New Jersey Medical School
Newark,  New Jersey,  07107-3001
United States
 

Nashville VA Medical Center
Nashville,  Tennessee,  37212-2637
United States
 

New York University School of Medicine
New York City,  New York,  10016
United States
 

Thomas Street Clinic
Houston,  Texas,  77009
United States
 

Boston Medical Center
Boston,  Massachusetts,  02118
United States
 

Carolinas Medical Center
Charlotte,  North Carolina,  28203
United States
 

Harlem Hospital Center
New York City,  New York,  10037
United States
 

University of North Texas Health Science Center
Ft. Worth,  Texas,  76107-2699
United States
 

Denver Department of Public Health and Hospitals
Denver,  Colorado,  80204
United States
 

University of California, San Francisco
San Francisco,  California,  94110
United States
 

University of Manitoba
Winnipeg,  Manitoba,  CANADA R3A 1R8
Canada
 

Washington, D.C. VAMC
Washington D.C.,  District of Columbia,  20422
United States
 

Columbia University/Presbyterian Medical Center
New York City,  New York,  10032
United States
 

Central Arkansas Veterans Health System
Little Rock,  Arkansas,  72205
United States
 

Seattle King County Health Department
Seattle,  Washington,  98104
United States
 

University of British Columbia
Vancouver,  British Columbia,  Canada V5Z 4R4
Canada
 

Audi L. Murphy VA Hospital
San Antonio,  Texas,  78284
United States
 

Montreal Chest Institute McGill University
Montreal,  Quebec,  H2X 2P4Pq Canada
Canada
 

Johns Hopkins University School of Medicine
Baltimore,  Maryland,  21287-0003
United States
 

LA County/USC Medical Center
Los Angeles,  California,  90033
United States
 

Chicago VA Medical Center (Lakeside)
Chicago,  Illinois,  60611
United States
 


Additional Information:
Study ID Numbers:
  2404;  25,HCK45
Study Start Date: July 1999
Record last reviewed: March 1999
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00023426

Other Tuberculosis Studies:
1. Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis

2. Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-desacetyl Rifapentine

3. Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients with HIV-Related Tuberculosis Treated with a Rifabutin-Based Regimen

4. Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis

5. Disseminated Tuberculosis in HIV Infection

Related Studies:

Other Tuberculosis Clinical Trials
Other Maryland Clinical Trials
Other Baltimore Clinical Trials

Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis

Modify your Search

  Other Tuberculosis Clinical Trials
  Other Maryland Clinical Trials
  Other Baltimore Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103